Cancer Gene Therapy Market 2025 to 2034
Cancer Gene Therapy Market 2025 to 2034
Cancer Gene Therapy Market (By Therapy: Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer; By End-User: Hospitals, Biopharmaceutical Companies, Diagnostic Centers, Research Institutes, Others; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 4.14 Bn
Forecast Year, 2034
USD 19.97 Bn
CAGR, 2025 - 2034
19.23%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global cancer gene therapy market, valued at USD 4.14 billion in 2025, is projected to reach USD 19.97 billion by 2034, expanding at a robust CAGR of 19.23%, driven by advancements in targeted therapies and rising oncology investments.
Cancer Gene Therapy Market Size Analysis
Cancer Gene Therapy Market Size By_Therapy 2025 to 2034 (USD Billion)
| By_Therapy | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gene Induced Immunotherapy | 1.66 | 1.96 | 2.32 | 2.74 | 3.25 | 3.85 | 4.55 | 5.39 | 6.38 | 7.56 |
| Oncolytic Virotherapy | 1.45 | 1.73 | 2.06 | 2.45 | 2.92 | 3.48 | 4.15 | 4.94 | 5.89 | 7.02 |
| Gene Transfer | 1.03 | 1.25 | 1.51 | 1.82 | 2.20 | 2.65 | 3.19 | 3.85 | 4.63 | 5.58 |
Cancer Gene Therapy Market Size By_EndUser 2025 to 2034 (USD Billion)
| By_EndUser | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 1.24 | 1.44 | 1.68 | 1.96 | 2.28 | 2.66 | 3.10 | 3.63 | 4.24 | 4.96 |
| Biopharmaceutical Companies | 1.03 | 1.22 | 1.43 | 1.68 | 1.98 | 2.33 | 2.74 | 3.23 | 3.81 | 4.50 |
| Diagnostic centers | 0.62 | 0.75 | 0.90 | 1.08 | 1.30 | 1.57 | 1.88 | 2.26 | 2.71 | 3.26 |
| Research Institutes | 0.83 | 1.00 | 1.20 | 1.45 | 1.74 | 2.09 | 2.51 | 3.01 | 3.62 | 4.34 |
| Others | 0.41 | 0.53 | 0.67 | 0.85 | 1.07 | 1.33 | 1.65 | 2.04 | 2.52 | 3.10 |
Cancer Gene Therapy Market Size By_Region 2025 to 2034 (USD Billion)
| By_Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.16 | 1.35 | 1.57 | 1.83 | 2.13 | 2.49 | 2.91 | 3.40 | 3.98 | 4.65 |
| Europe | 0.99 | 1.17 | 1.37 | 1.62 | 1.90 | 2.24 | 2.64 | 3.12 | 3.68 | 4.34 |
| Asia Pacific | 0.91 | 1.08 | 1.29 | 1.53 | 1.82 | 2.17 | 2.58 | 3.07 | 3.65 | 4.34 |
| Latin America | 0.62 | 0.76 | 0.93 | 1.13 | 1.37 | 1.66 | 2.01 | 2.44 | 2.95 | 3.57 |
| Middle East and Africa | 0.46 | 0.58 | 0.73 | 0.91 | 1.14 | 1.42 | 1.75 | 2.16 | 2.66 | 3.26 |
Cancer Gene Therapy Market Size to Lead USD 19.97 Billion by 2034
The global cancer gene therapy market size accounted for USD 4.14 billion in 2025 and is predicted to touch around USD 19.97 billion by 2034 a CAGR of 19.23%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
